CY2494B1 - Cephalosporin synthesis. - Google Patents

Cephalosporin synthesis.

Info

Publication number
CY2494B1
CY2494B1 CY0400084A CY0400084A CY2494B1 CY 2494 B1 CY2494 B1 CY 2494B1 CY 0400084 A CY0400084 A CY 0400084A CY 0400084 A CY0400084 A CY 0400084A CY 2494 B1 CY2494 B1 CY 2494B1
Authority
CY
Cyprus
Prior art keywords
denotes
hydrogen
group
silyl group
denote
Prior art date
Application number
CY0400084A
Other languages
English (en)
Inventor
Gerd Ascher
Johannes Ludescher
Hubert Sturm
Josef Wieser
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0085894A external-priority patent/AT402072B/de
Priority claimed from AT85794A external-priority patent/AT402927B/de
Priority claimed from AT0106694A external-priority patent/AT402929B/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CY2494B1 publication Critical patent/CY2494B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cephalosporin Compounds (AREA)
CY0400084A 1994-04-25 2004-11-24 Cephalosporin synthesis. CY2494B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0085894A AT402072B (de) 1994-04-25 1994-04-25 Cephemderivate und verfahren zu ihrer herstellung
AT85794A AT402927B (de) 1994-04-25 1994-04-25 Neue cefalosporinderivate, verfahren zu ihrer herstellung und ihre verwendung
AT0106694A AT402929B (de) 1994-05-25 1994-05-25 Neue cephalosporinderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
CY2494B1 true CY2494B1 (en) 2005-09-02

Family

ID=27146806

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400084A CY2494B1 (en) 1994-04-25 2004-11-24 Cephalosporin synthesis.

Country Status (26)

Country Link
US (4) US5856474A (cs)
EP (2) EP0757691B1 (cs)
JP (1) JP3302369B2 (cs)
KR (1) KR100487833B1 (cs)
CN (3) CN1145628C (cs)
AT (2) ATE244247T1 (cs)
AU (1) AU686380B2 (cs)
BR (1) BR9507512A (cs)
CA (2) CA2533837A1 (cs)
CY (1) CY2494B1 (cs)
CZ (1) CZ297565B6 (cs)
DE (2) DE69531203T2 (cs)
DK (1) DK0757691T3 (cs)
ES (1) ES2202362T3 (cs)
FI (1) FI963761L (cs)
HU (3) HU0102726D0 (cs)
MX (1) MX9604353A (cs)
NO (1) NO318020B1 (cs)
NZ (2) NZ329984A (cs)
PL (2) PL182864B1 (cs)
PT (1) PT757691E (cs)
RU (2) RU2225411C2 (cs)
SI (1) SI0757691T1 (cs)
SK (1) SK285948B6 (cs)
TW (1) TW427992B (cs)
WO (1) WO1995029182A1 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248881B1 (en) * 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
US5856474A (en) * 1994-04-25 1999-01-05 Biochemie Gesellschaft, M.B.H. Cephalosporin synthesis
US6384214B1 (en) 1999-07-05 2002-05-07 Basilea Pharmaceutica Ag Process for producing cephalosporin derivatives
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
JP4969013B2 (ja) 2000-06-21 2012-07-04 キュービスト ファーマスーティカルズ インコーポレイテッド 抗菌剤の経口吸収を改善するための組成物および方法
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2533358C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528189A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
AU2006242535B2 (en) * 2005-04-29 2012-08-09 Merck Sharp & Dohme Corp. Therapeutic compositions
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2010136423A1 (de) * 2009-05-25 2010-12-02 Sandoz Ag Verfahren zur herstellung von ceftobiprol medocaril
ITMI20131820A1 (it) * 2013-11-04 2015-05-05 Laboratorio Chimico Int Spa Procedimento per la preparazione di olopatadina
CN109180704B (zh) * 2018-11-19 2020-06-05 齐鲁安替制药有限公司 一种头孢妥仑匹酯的合成方法
KR20220061163A (ko) 2019-09-06 2022-05-12 나브리바 테라퓨틱스 게엠베하 사이드로포어 세팔로스포린 접합체 및 이의 용도

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3351596A (en) * 1966-09-21 1967-11-07 Lilly Co Eli 3-formyl cephalosporins
US3769277A (en) 1970-01-23 1973-10-30 Glaxo Lab Ltd Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group
CH546794A (de) * 1970-06-18 1974-03-15 Ciba Geigy Ag Verfahren zur herstellung von cephalosporansaeurederivaten.
CH556876A (de) * 1971-05-19 1974-12-13 Ciba Geigy Ag Verfahren zur herstellung von cephalosporansaeurederivaten.
US3674784A (en) * 1970-07-27 1972-07-04 Lilly Co Eli 3-formyl cephalosporin sulfoxides
GB1368231A (en) * 1970-07-31 1974-09-25 Glaxo Lab Ltd Thio-substituted azetidinones and thiazolino azetidinones
US3880851A (en) * 1971-12-24 1975-04-29 Lilly Co Eli Antibiotic method
CA1109860A (en) * 1972-12-08 1981-09-29 Shinji Terao Process for producing lactol-type cephalosporins
JPS49109391A (cs) * 1973-02-28 1974-10-17
JPS5093989A (cs) * 1973-10-25 1975-07-26
JPS5071691A (cs) * 1973-11-02 1975-06-13
JPS5129492A (en) * 1974-09-04 1976-03-12 Sankyo Co Sefuarosuhorinjudotai no seiho
GB1447959A (en) * 1975-02-27 1976-09-02 Shionogi & Co Process for preparing cephem aldehyde derivatives
US4101658A (en) * 1975-06-04 1978-07-18 Shionogi & Co., Ltd. Antibacterial hydrazono cephalosporins
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
US5081116A (en) 1989-04-12 1992-01-14 Yamanouchi Pharmaceutical Co., Ltd. Cephalosporin derivatives
JP2895900B2 (ja) * 1990-03-08 1999-05-24 大塚化学株式会社 ３―ホルミルセフエム誘導体の製造法
DK0503453T3 (da) * 1991-03-08 2001-07-16 Biochemie Gmbh Fremgangsmåde til fremstilling af cephalosporiner og mellemprodukter i denne fremgangsmåde
AT400436B (de) * 1992-11-10 1995-12-27 Biochemie Gmbh Neues verfahren zur herstellung von 3-vinylcephalosporinverbindungen
ES2185634T3 (es) 1993-04-16 2003-05-01 Basilea Pharmaceutica Ag Derivados de cefalosporina.
US5856474A (en) * 1994-04-25 1999-01-05 Biochemie Gesellschaft, M.B.H. Cephalosporin synthesis

Also Published As

Publication number Publication date
PL182864B1 (pl) 2002-03-29
EP0757691A1 (en) 1997-02-12
WO1995029182A1 (en) 1995-11-02
JPH09512259A (ja) 1997-12-09
SK285948B6 (sk) 2007-11-02
CN1326935A (zh) 2001-12-19
KR970702284A (ko) 1997-05-13
EP1340762B1 (en) 2011-02-16
ATE498627T1 (de) 2011-03-15
RU2150471C1 (ru) 2000-06-10
RU2225411C2 (ru) 2004-03-10
ES2202362T3 (es) 2004-04-01
NZ285084A (en) 1998-05-27
SK135796A3 (en) 1997-05-07
CN1145628C (zh) 2004-04-14
DK0757691T3 (da) 2003-10-27
JP3302369B2 (ja) 2002-07-15
DE69531203T2 (de) 2004-04-22
CA2180829C (en) 2008-06-03
CN1344720A (zh) 2002-04-17
CA2533837A1 (en) 1995-11-02
HUT75229A (en) 1997-04-28
CA2180829A1 (en) 1995-11-02
CZ297565B6 (cs) 2007-02-07
FI963761A7 (fi) 1996-09-20
NO964493L (no) 1996-10-23
PT757691E (pt) 2003-11-28
US6063917A (en) 2000-05-16
HU0102725D0 (en) 2001-08-28
EP0757691B1 (en) 2003-07-02
CN1145629C (zh) 2004-04-14
DE69531203D1 (en) 2003-08-07
CN1092662C (zh) 2002-10-16
MX9604353A (es) 1997-06-28
HU9602940D0 (en) 1996-12-30
US6093813A (en) 2000-07-25
EP1340762A1 (en) 2003-09-03
CZ310696A3 (en) 1997-01-15
NO318020B1 (no) 2005-01-24
DE69536140D1 (de) 2011-03-31
TW427992B (en) 2001-04-01
KR100487833B1 (ko) 2005-10-14
FI963761A0 (fi) 1996-09-20
AU2407295A (en) 1995-11-16
US6034237A (en) 2000-03-07
PL316661A1 (en) 1997-02-03
PL184773B1 (pl) 2002-12-31
SI0757691T1 (en) 2003-12-31
ATE244247T1 (de) 2003-07-15
BR9507512A (pt) 1997-09-02
NO964493D0 (no) 1996-10-23
CN1146770A (zh) 1997-04-02
HU0102726D0 (en) 2001-08-28
FI963761L (fi) 1996-09-20
AU686380B2 (en) 1998-02-05
US5856474A (en) 1999-01-05
NZ329984A (en) 1998-06-26

Similar Documents

Publication Publication Date Title
HU9602940D0 (en) Cephalosporin synthesis
EP0592677A4 (en) -g(b)-lactam compound and cephem compound, and production thereof
CA2324959A1 (en) Phthalimido compounds as intermediates for producing substance p receptor antagonists
FI853737L (fi) Foerfarande foer framstaellning av optiskt aktiva acyloxiazetidinoner.
ZA93267B (en) Novel arylcyloakyl derivatives their production and their use
ATE181066T1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
CA2103072A1 (en) Pleuromutilin derivatives
AU2740992A (en) Dental cement
IE840230L (en) Azetidinones.
GR3036405T3 (en) Novel intermediate for synthetic use and process for producing aminopiperazine derivative
GB8702139D0 (en) Process
TW277059B (cs)
DE3269494D1 (en) Novel intermediates and process for preparing (s)-3-acylamino-4-substituted-2-azetidinones
GB8614710D0 (en) Process
TW239123B (cs)
ES8203379A1 (es) Un procedimiento para la preparacion de carbapenemas